MGMT and glioblastoma: In our study, we aimed to investigate overall survival (OS) and progression‐free survival (PFS) in GBM with dual inactivation of MGMT (by methylation of its promoter and chromosome 10q26.3 loss) versus simple inactivation of MGMT (by one of the previously cited mechanisms).